Evidence map›Paper›PMID 36333615›Full record

ArticleDermatology and therapy2022

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature.

Grażyna Kamińska-Winciorek, Katarzyna Galwas, Magdalena Suchorzepka, Barbara Ziółkowska, Maria Turska-d'Amico, Wiesław Bal, Claudio Conforti, Ludovica Toffoli, Bożena Cybulska-Stopa, Iris Zalaudek

Open access · goldAbstract read
In one paragraph

Article in Dermatology and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Giant thick melanomas: a retrospective case series.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Grażyna Kamińska-WinciorekDepartment of Bone Marrow Transplantation and Onco-Hematology, Skin Cancer and Melanoma Team, Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO), Gliwice Branch, Wybrzeże Armii Krajowej 15, 44-101, Gliwice, Poland. dermatolog.pl@gmail.com.ORCID http://orcid.org/0000-0002-9810-4945
Katarzyna Galwas2nd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
Magdalena SuchorzepkaTumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
Barbara Ziółkowska2nd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
Maria Turska-d'AmicoDepartment of Oncological and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
Wiesław BalDepartment of Outpatient Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
Claudio ConfortiDermatology Clinic of Trieste, Maggiore Hospital, University of Trieste, Trieste, Italy.
Ludovica ToffoliDermatology Clinic of Trieste, Maggiore Hospital, University of Trieste, Trieste, Italy.
Bożena Cybulska-StopaClinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Cracow Branch, Warszawa, Poland.
Iris ZalaudekDermatology Clinic of Trieste, Maggiore Hospital, University of Trieste, Trieste, Italy.
The Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity of Trieste · ITNational Institute of Oncology · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNodular melanoma (NM) is a rare subtype of melanoma, responsible for more than 40% of melanoma deaths, characterized by rapid growth and high metastatic potential. Only a few case studies concerning the dermoscopic presentations of giant nodular melanoma have been reported so far.

objectivesThe aim of the study was to assess dermoscopic features of giant nodular melanomas in special locations, along with their clinical and histopathologic aspects.

methodsAmong 120 patients with histopathologically confirmed melanoma treated by the Skin Cancer and Melanoma Team between September 2020 and February 2021, we identified six patients with giant nodular melanoma in special locations. We retrospectively assessed the archived dermoscopic images to determine the dermoscopic features of these tumors.

resultsThe group consisted of six cases of giant melanoma in special locations, including the scalp (4/6) and the heel (2/6). The giant tumors were large in size (at least 5 cm in diameter). The most common dermoscopic structures in polarized light included asymmetric distribution of dermoscopic structures, the presence of structureless, multicolored zones (showing three or more colors), and the presence of white perpendicular lines or small, pink globules.

conclusionsIt seems that there are no significant differences in dermoscopy between small and giant melanomas; however, further studies should be conducted on a larger scale.

Indexed as

AcralDermoscopyGiant melanomaScalpSpecial location

Identifiers

PMID36333615
PMCPMC9638227
OpenAlexW4308327553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.